AI × Optical Biosensing · Mass Production 2026

No needles. Just one ring that measures glucose.

Near-infrared optical sensing meets proprietary AI algorithms in
the world's first ring-type, fully non-invasive glucose monitor.
Redesigning daily life for 463 million people living with diabetes.

Explore the Technology Investor & Partnership Inquiry
463MDiabetes patients worldwide
$28B2026 CGM market size
0Needles · No patch replacement
Nano Miracle Smart Ring
NIR SensorMulti-wavelength optics
AI Algorithm3-stage noise reduction
72h BatteryReal-time 24/7 monitoring
SCROLL
● 100% Non-Invasive● Zero Pain● No Patch Replacement ● Up to 50% Cost Savings over 6 Months● Target MARD 12% ● TIPS Selected● Seoul National University Bundang Hospital Clinical Partner● Mass Production 2026 ● 100% Non-Invasive● Zero Pain● No Patch Replacement ● Up to 50% Cost Savings over 6 Months● Target MARD 12% ● TIPS Selected● Seoul National University Bundang Hospital Clinical Partner● Mass Production 2026
01 · The Problem

The diabetes era is here.
But monitoring is still painful.

463 million people worldwide live with diabetes today. By 2045, this is projected to reach 700 million — 10.9% of the global population. Yet today's continuous glucose monitors (CGMs) still burden patients with high costs, accuracy issues, and skin irritation.

01

$150–230
monthly burden

Disposable sensors and patches must be replaced every 15 days. Six-month cumulative cost can exceed $800.

02

10%+
measurement error

Interstitial fluid sampling causes a 5–15 minute delay and reduces accuracy compared to direct blood readings.

03

Skin irritation
& allergic reactions

Adhesive patches cause rashes, allergies, and disturbed sleep — common complaints from long-term users.

04

Import-dependent
market structure

Global market is dominated by foreign players (Dexcom, Abbott). No competitive domestic Korean alternative exists.

02 · Our Solution

A single ring is about to
redefine glucose monitoring.

No needles. No patches. No replacements. From the moment you slip it on your finger, real-time 24-hour monitoring begins.

NM-Ring product render
  • ◐

    100% Non-Invasive

    Optical sensors measure blood glucose directly through the skin. Zero pain, zero infection risk, zero replacement cost.

  • ⌬

    Ring Form Factor

    Titanium alloy shell, Ø20mm × 3mm thin. IPX8 waterproof, 72-hour continuous operation on a single charge.

  • ⌁

    Real-Time AI Analysis

    Wavelet transform + PCA + tree-based ensemble ML deliver 3-stage noise reduction with instant estimation.

  • $

    Up to 50% Cost Reduction

    No disposables, no replacements. Over six months, dramatically more economical than traditional CGMs.

03 · Technology

Near-Infrared Optics × AI,
backed by deep-tech foundations.

Multi-wavelength NIR optics and our in-house machine learning algorithms combine to power the world's first ring-form glucose monitoring architecture.

CORE-TECH 01

Near-Infrared Wavelength
Glucose Monitoring Algorithm

A proprietary AI algorithm that composites background signals with glucose-responsive wavelengths. Korean patent filed (No. 10-2024-0104923).

  • Wavelet transform-based signal preprocessing
  • PCA-driven feature extraction
  • Tree-based ensemble ML prediction
R² 0.92Algorithm determination
MARD 15→12%Target international standard
CORE-TECH 02

Multi-LED Sensing
Optimized Hardware

High-sensitivity optical measurement architecture based on 2-axis offset placement. Integrates multi-wavelength NIR + temperature + humidity sensors.

  • Precision Z-axis LED-sensor spacing
  • Hardware-level algorithm with process tolerance correction
  • Korean patent filed (No. 10-2024-0104924)
3Integrated sensors
4Core patents filed
Validation

Validated by Samsung Fire & TIPS

June 2025 live demonstration: traditional blood sampling reading of 111 mg/dL vs. Nano Miracle non-invasive reading of 102 mg/dL — comparable accuracy confirmed.

Clinical

Clinical Partnership with SNUBH

Signed exploratory clinical MOU with Seoul National University Bundang Hospital spin-off. Preparing IRB submission for a 30-patient exploratory study.

04 · Product

Forget the clunky devices.
A wearable that disappears into daily life.

NM-Ring exploded internal structure
Exploded View · Internal Architecture

NM-Ring · Prototype v3

From stick-type prototype to a miniaturized ring-form complete product. PCB design, mold development, and mass production preparation are now underway.

  • Form FactorSmart Ring
  • MeasurementNear-Infrared Non-Invasive
  • DimensionsØ 20mm · 3mm thick
  • MaterialTitanium Alloy
  • Water ResistanceIPX8
  • Battery Life72 hours
  • Measurement CycleReal-time 24/7
  • ConnectivityDedicated Mobile App (BLE)
PrecisionAI algorithm integration
ConvenienceRing form factor
Innovation100% non-invasive
CLINICAL VALIDATION

Live Demo · Validated by Samsung Fire TIPS

On June 16, 2025, during Samsung Fire's TIPS investment review, we benchmarked our
non-invasive ring against traditional finger-prick measurement in real time — and proved practical-grade accuracy.

Finger-Prick (Traditional)111 mg/dL
≈
NM-Ring (Non-Invasive)102 mg/dL

Refined design. Premium detail.

White PC shell + transparent inner layer + top laser-etched logo · Precision 30 × 32 × 14mm form factor

NM-Ring Top View
TOP VIEWLaser-etched logo finish
NM-Ring Isometric
ISOMETRIC3/4 wearable perspective
NM-Ring Bottom Sensor
SENSOR SIDEInner optical sensor & charging contacts
NM-Ring Dimensions
DIMENSIONInner Ø 19mm · Outer Ø 30mm
05 · Why Nano Miracle

More convenient.
Dramatically more affordable.

Over 6 months of usage, our single-device model with no disposables delivers radical long-term economy compared to subscription-based CGMs.

Region
Product
Initial Price
6-Month Total
Non-Invasive
KR Domestic
CareSens Air
~$65
~$780
✕ Patch-based
US Global
FreeStyle Libre
~$73
~$876
✕ Patch-based
US Global
Dexcom G7
~$70
~$848
✕ Patch-based
NM Nano Miracle
NM-Ring
$400
$400 (no recurring cost)
✓ 100% Non-Invasive

Market Positioning Map

X-axis = Price Competitiveness · Y-axis = Non-Invasiveness

↑ Non-Invasiveness Price Competitiveness →
Nano Miracle
Dexcom
Libre
CareSens
Barozen

Key Takeaways

  1. White space confirmed. All four major domestic and global competitors rely on invasive or patch-based methods.
  2. Daily wearability wins. Our ring form factor enables natural wear during sleep, exercise, and showering.
  3. TCO advantage. Long-term cost savings of 50–70% over traditional CGMs.
06 · Market Opportunity

Just 1% of the market is ~$300M per year.

The CGM market is growing explosively, and the entry of giants like Apple and Samsung into non-invasive glucose monitoring proves a paradigm shift is underway.

TAM • Total Addressable

$6B

Estimated based on 15.4 million potential global purchasers among the diabetic population.

SAM • Serviceable

$300M

Initial adopters: 0.1% of the diabetic population (~800,000 people) represent our addressable market.

SOM • Obtainable

25,000

Initial Korean target: 25,000 early adopters through D2C online channels and pharmacy partnerships.

2026 CGM Market

$28B

A fast-growing market where Apple, Samsung, and other global tech giants are racing into non-invasive glucose monitoring.

07 · Business Model

Beyond measurement. Toward management.
An AI-powered diabetes healthcare revolution.

BM 01

Hardware Sales

Direct sales of the fully non-invasive optical glucose monitoring ring. B2C online + pharmacy channels + B2B partnerships with corporate wellness programs and insurers.

Device
BM 02

AI Healthcare Platform

Beyond simple measurement: personalized diet & exercise coaching, cardiac health expansion, and a recurring-revenue wellness subscription service.

Subscription
BM 03

Enterprise AI Solutions

Autonomous robotics AI, infertility CDSS, AR mobile apps, FPGA-based gait control AI, and other B2B AI projects deliver stable cash flow.

B2B AI
08 · Roadmap

From core technology to IPO,
an 8-year journey.

  1. 2022

    Core Technology Development

    SNU Graduate Demo Day Excellence Award · Selected for Lab-Specialized Startup Program · Core patents filed.

  2. 2023

    Prototype Refinement

    SNU Prototype Manufacturing Support selected · Stick-type glucose monitor prototype built · Hardware core patents filed.

  3. 2024

    Ring-Form Prototype

    AI-based ring mockup design · ISO standard compliance verified · Multi-wavelength NIR optics validated.

  4. 2025

    Seed Funding · TIPS Award

    Youth Startup Academy admission · Seed investment from Kingsley Ventures · TIPS R&D award · Venture company certification.

  5. 2026

    Mass Production & Initial Launch

    Ring-form mass production · KC certification · $250K revenue target · BIO KOREA / BIO USA / KHF / MEDICA expo participation.

  6. 2027

    Wellness Product Test Sales

    Healthcare platform MVP launch · FDA / CE certification process · $400K annual wellness revenue.

  7. 2029

    Global AI Diagnostics Company

    Confirmatory clinical trial completion · Innovative Medical Device certification · FCC/CE global certification · Expansion into Japan, Southeast Asia, and Europe.

  8. 2030

    IPO

    20,000 units/year · ~$8M annual revenue · KOSDAQ listing · Established as a global AI biodata leader.

09 · Team

Led by a Seoul National University PhD,
built by bio & AI specialists.

CEO · Founder

Kyu-Bok Lee

Ph.D · Engineering

  • Ph.D, Applied Bioengineering, Seoul National University
  • 15 SCI publications in biosensors and biomaterials
  • Expert in optical & AI-based sensor research · Multiple patents
Technical Advisory

Dong-Woo Kim

Ph.D · Engineering

  • Ph.D, Applied Bioengineering, Seoul National University
  • Specialist in biomaterials and biosensor research
  • Advises technology refinement and commercialization
Regulatory Affairs

Yeon-Jae Woo

M.S.

  • M.S., Medical Device Industry, Yonsei University
  • Specialist in medical device approvals & clinical documentation
  • Leads KC / FDA / CE certification track
Project Manager

Chan-Dong Kim

B.S.

  • B.S., National Institute for Lifelong Education
  • Expertise in government documentation & clinical training
  • Software development & operations lead

Partners & Certifications

Seoul National University SNU Bundang Hospital Samsung Fire · TIPS Kingsley Ventures Veterans Health Service Medical Center Eggbomb · Clinical Partner AiderBio SUNIN Corp ICADMan GP KOREA iPLAN Youth Startup Academy Korea Technology Finance · Venture Certified Certified R&D Department
Our Vision

"A world where anyone can manage their glucose
painlessly, affordably, and effortlessly — anytime, anywhere."

Nano Miracle is not just a medical device prototype. We are redesigning the daily lives of hundreds of millions of people living with — or at risk of — diabetes.
Join us on this journey.

Partnership Inquiry contact@nanomiracle.net